ALPS Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.04M | Sell |
17,180
-1,518
| -8% | -$541K | 0.03% | 227 |
|
|
2025
Q4 | $6.12M | Sell |
18,698
-61
| -0.3% | -$19.4K | 0.04% | 224 |
|
|
2025
Q3 | $5.29M | Buy |
18,759
+7,254
| +63% | +$2.1M | 0.03% | 244 |
|
|
2025
Q2 | $3.21M | Sell |
11,505
-96
| -0.8% | -$27.2K | 0.02% | 293 |
|
|
2025
Q1 | $3.61M | Buy |
11,601
+1,152
| +11% | +$340K | 0.02% | 271 |
|
|
2024
Q4 | $2.72M | Sell |
10,449
-1,462
| -12% | -$434K | 0.02% | 305 |
|
|
2024
Q3 | $3.84M | Sell |
11,911
-13,089
| -52% | -$4.28M | 0.03% | 265 |
|
|
2024
Q2 | $7.81M | Buy |
25,000
+1,713
| +7% | +$503K | 0.05% | 187 |
|
|
2024
Q1 | $6.62M | Sell |
23,287
-1,010
| -4% | -$296K | 0.05% | 200 |
|
|
2023
Q4 | $7M | Sell |
24,297
-55
| -0.2% | -$15K | 0.06% | 182 |
|
|
2023
Q3 | $6.54M | Sell |
24,352
-7,066
| -22% | -$1.76M | 0.05% | 167 |
|
|
2023
Q2 | $6.98M | Sell |
31,418
-833
| -3% | -$193K | 0.06% | 168 |
|
|
2023
Q1 | $7.8M | Sell |
32,251
-3,090
| -9% | -$759K | 0.07% | 148 |
|
|
2022
Q4 | $9.28M | Sell |
35,341
-101,301
| -74% | -$27.2M | 0.08% | 148 |
|
|
2022
Q3 | $30.8M | Sell |
136,642
-31,007
| -18% | -$7.52M | 0.29% | 49 |
|
|
2022
Q2 | $40.8M | Buy |
167,649
+60,453
| +56% | +$14.8M | 0.4% | 28 |
|
|
2022
Q1 | $25.9M | Sell |
107,196
-3,019
| -3% | -$694K | 0.28% | 55 |
|
|
2021
Q4 | $24.8M | Buy |
+110,215
| New | +$23.3M | 0.28% | 54 |
|
|
2021
Q1 | – | Sell |
-1,066
| Closed | -$245K | – | 866 |
|
|
2020
Q4 | $245K | Sell |
1,066
-21
| -2% | -$4.84K | ﹤0.01% | 823 |
|
|
2020
Q3 | $276K | Buy |
1,087
+114
| +12% | +$28.2K | ﹤0.01% | 577 |
|
|
2020
Q2 | $229K | Sell |
973
-108
| -10% | -$24.6K | ﹤0.01% | 710 |
|
|
2020
Q1 | $219K | Sell |
1,081
-8,100
| -88% | -$1.77M | ﹤0.01% | 714 |
|
|
2019
Q4 | $2.21M | Sell |
9,181
-372
| -4% | -$82K | 0.02% | 219 |
|
|
2019
Q3 | $1.85M | Sell |
9,553
-3,964
| -29% | -$761K | 0.01% | 217 |
|
|
2019
Q2 | $2.49M | Sell |
13,517
-206
| -2% | -$36.9K | 0.02% | 206 |
|
|
2019
Q1 | $2.61M | Sell |
13,723
-7,192
| -34% | -$1.37M | 0.02% | 201 |
|
|
2018
Q4 | $4.07M | Buy |
20,915
+127
| +0.6% | +$24.8K | 0.03% | 169 |
|
|
2018
Q3 | $4.31M | Buy |
20,788
+12,226
| +143% | +$2.41M | 0.03% | 176 |
|
|
2018
Q2 | $1.58M | Buy |
8,562
+3,556
| +71% | +$629K | 0.01% | 254 |
|
|
2018
Q1 | $853K | Sell |
5,006
-519
| -9% | -$95.3K | 0.01% | 343 |
|
|
2017
Q4 | $961K | Buy |
5,525
+276
| +5% | +$48.8K | 0.01% | 270 |
|
|
2017
Q3 | $979K | Buy |
5,249
+349
| +7% | +$61.8K | 0.01% | 244 |
|
|
2017
Q2 | $844K | Buy |
4,900
+2,120
| +76% | +$345K | 0.01% | 251 |
|
|
2017
Q1 | $456K | Buy |
2,780
+20
| +0.7% | +$3.32K | ﹤0.01% | 635 |
|
|
2016
Q4 | $404K | Sell |
2,760
-102
| -4% | -$15.4K | ﹤0.01% | 585 |
|
|
2016
Q3 | $477K | Buy |
+2,862
| New | +$484K | ﹤0.01% | 290 |
|
|
2016
Q1 | – | Sell |
-3,187
| Closed | -$517K | – | 632 |
|
|
2015
Q4 | $517K | Sell |
3,187
-100
| -3% | -$15.7K | 0.01% | 407 |
|
|
2015
Q3 | $4.55K | Buy |
3,287
+49
| +2% | +$7.72K | ﹤0.01% | 567 |
|
|
2015
Q2 | $497K | Buy |
3,238
+50
| +2% | +$8.01K | ﹤0.01% | 519 |
|
|
2015
Q1 | $510K | Sell |
3,188
-513
| -14% | -$80.8K | ﹤0.01% | 542 |
|
|
2014
Q4 | $590K | Sell |
3,701
-504
| -12% | -$78.5K | ﹤0.01% | 287 |
|
|
2014
Q3 | $591K | Sell |
4,205
-550
| -12% | -$71.8K | ﹤0.01% | 315 |
|
|
2014
Q2 | $563K | Buy |
4,755
+120
| +3% | +$13.9K | ﹤0.01% | 461 |
|
|
2014
Q1 | $572K | Buy |
4,635
+461
| +11% | +$55.9K | 0.01% | 420 |
|
|
2013
Q4 | $496K | Buy |
4,174
+2,030
| +95% | +$231K | 0.01% | 389 |
|
|
2013
Q3 | $240K | Buy |
+2,144
| New | +$232K | ﹤0.01% | 554 |
|
Other funds holding AMGN
VCM
VPM
ALPS Advisors's AMGN Position: Q1 2026 in Review
ALPS Advisors reduced its Amgen (AMGN) stake by 8.1% in Q1 2026, selling an estimated $541K and leaving 17,180 shares worth $6.04M. The position accounts for 0.03% of the portfolio, ranked #227.
ALPS Advisors first reported a position in AMGN in Q3 2013 and has held it in 46 quarters since. The position peaked at $40.8M in Q2 2022. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- ALPS Advisors held 17,180 shares of Amgen worth $6.04M as of Q1 2026.
- ALPS Advisors sold 1,518 Amgen shares in Q1 2026, an estimated $541K.
- Amgen made up 0.03% of ALPS Advisors's portfolio in Q1 2026, its #227 holding.
- ALPS Advisors first reported a position in Amgen in Q3 2013 and has held it in 46 quarters since.
- ALPS Advisors's Amgen position peaked at $40.8M in Q2 2022.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.